1998
- January 1998 foundation of PlasmaSelect GmbH

1999
- November 1999 conversion to PlasmaSelect AG

2000
- IPO March 1, 2000

2001
- Acquisition of DeltaPharma (DeltaSelect) in Pfullingen
- Acquisition of Klemenz (infusion solutions factory) in Pfullingen
- Objective: alternative business, basic business

2002
In October 2002, sale of adsorber technology and the respective plant in Teterow

2003
- Takeover of RenaSelect, Pirna
- Acquisition of Pierrel Medical Care (in future AltaSelect), Potenza/Italy
- Acquisition of the AINS business division of curasan AG by DeltaSelect
- Acquisition of the product areas Bupivacain and Meaverin of Aventis Pharma Deutschland GmbH through DeltaSelect
- Move into new business premises in Munich, Pettenkoferstrasse

2004
– Takeover of the Haemaccel®-Division from Aventis Pharma inclusive the manufacturing plant in Marburg/Hessen
– Takeover of the assets from CuraMED Pharma GmbH by DeltaSelect

2005
- Takeover of the injectable generics business sector from Pierrel Farmaceutici S.p.A. in Milan, Italy

2006
- Began selective sales in private practices/medical care centres
- Discontinuation of development of dialysers at the Pirna site and the split off of RenaSelect GmbH & Co. KG from the Group
- Name change from Pierrel Medical Care S.p.A. to NovaSelect S.p.A.
- Acquisition of Farmaco Network B.V. in Barneveld, Netherlands

2007
- Sale of the Generic business segment to the Actavis Group

2008
- new board member, Mr. Bernhard Giessel, takes over his activities
- Participation on the Aquaworx AG
- Sale of the Haemaccel assets
- Decision to close the manufacturing plant in Marburg